Mack PC, Redman MW, Tukachinsky H, Kozono DE, Minichiello K, Dragnev KH, Tolba KA, Neal JW, Madison RW, Waqar SN, Aggarwal C, Hirsch FR, Patel JD, Herbst RS, Chiang AC, Reckamp KL, Kelly K, Borghaei H, Gray JE, Gandara DR. Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study , Clin Cancer Res: 2025
Teja Voruganti, Rosalyn Marar, Benjamin Bleiberg, Edoardo Garbo, Biagio Ricciuti, Kaushal Parikh, Charu Aggarwal Perioperative Therapy in Oncogene-Driven Non–Small Cell Lung Cancer: Current Strategies and Unanswered Questions , American Society of Clinical Oncology Educational Book, 45(3): 2025
Kamboj M, Kirkwood MK, Bohlke K, Gralow JR, Garrett-Mayer E, Aggarwal C. More Frequent than Annual Administration of COVID-19 Vaccination May Be Appropriate for Patients With Cancer , JCO Oncol Adv, 2: 2025,e2400107
Adam Barsouk, Omar Elghawy, Alex Watts, Lauren Reed-Guy, William Tompkins, Krishna Chandrasekhara, Connor B Grady, Wade Iams, Fangdi Sun, Geoffrey Liu, Devalben Patel, Jorge J Nieva, Kristen A Marrone, Vamsidhar Velcheti, Stephen V Liu, Tejas Patil, Jared Weiss, William Schwartzman, Liza C Villaruz, Amanda Hermann, Dara L Aisner, Wei-Ting Hwang, D Ross Camidge, Lova Sun, Aditi Puri Singh, Roger B Cohen, Charu Aggarwal, Corey J Langer, Melina E Marmarelis Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis , Lung Cancer, 203: 2025
Sun L, Marmarelis ME, Aggarwal C. Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer , Journal of Clinical Oncology: 2025
Melina E Marmarelis, Adrienne M Gilligan, Tomoko Sugihara, Shen Zheng, Tyler Marquart, Sam Whipple, Naleen Raj Bhandari, Charu Aggarwal HSR25-167: Real-World Study Demonstrates Lack of Biomarker-driven Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer That Received Next-Generation Sequencing Testing , Journal of the National Comprehensive Cancer Network, 23(3.5): 2025
Stalker M, Marmarelis M, Langer C, Cohen RB, Singh A, Aggarwal C, Sun L. Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC , Clin Lung Cancer, 26(2): 2025,124-130
Elghawy O, Barsouk A, Reed-Guy L, Stalker M, Sussman J, Robinson K, Kosteva J, Singh A, Cohen RB, Langer C, Ciunci C, D'Avella C, Sun L, Marmarelis ME, Aggarwal C. Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy , Clin Lung Cancer, 26(2): 2025,158-163
Reuss JE, Zaemes J, Gandhi N, Walker P, Patel SP, Xiu J, Aggarwal C, Vanderwalde A, Ramalingam SS, Halmos B, Liu SV. Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking , Lung Cancer, 200: 2025
Stabellini N, Makram OM, Kunhiraman HH, Daoud H, Shanahan J, Montero AJ, Blumenthal RS, Aggarwal C, Swami U, Virani SS, Noronha V, Agarwal N, Dent S, Guha A. A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer , JNCI Cancer Spectr, 9: 2025,pkaf016
